Nearly 40% of Type 2 diabetes patients stop taking their second line medication

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2023-12-14 03:45 GMT | Update On 2023-12-14 08:53 GMT

Most patients with Type 2 diabetes will end up needing to add a second-line medication after metformin-the go-to primary drug for glucose management-to control their blood sugar levels. But adherence to these second-line drugs can be hit or miss, reports a new Northwestern Medicine study.

When patients discontinue their medication, switch to a different drug or intensify their treatment (either via an increased dose, adding a third medication or starting insulin), it wastes the doctor and patient’s time, costs the health system unnecessary expense and, in the case of discontinuation, can result in a patient not fully treating their Type 2 diabetes. The study was published Dec. 12 in the American Journal of Managed Care.

The scientists analyzed five non-insulin classes of diabetes medications. In four of the five classes, 38% of patients discontinued their medication. But among patients prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), half (50%) discontinued treatment.

“Discontinuation is bad. It is common in all five types of medications, but we see significantly more in those prescribed the GLP-1 RAs,” said corresponding author David Liss, research associate professor of general internal medicine at Northwestern University Feinberg School of Medicine.

Reference: Nearly 40% of Type 2 diabetes patients stop taking their second-line medication; The American Journal of Managed Care; DOI: 10.37765/ajmc.2023.89466

Full View

Article Source : The American Journal of Managed Care

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Preksha garg

Preksha Garg is a B. Pharma graduate and is currently working as a medical content writer at Medical Dialogues.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Nearly 40% of Type 2 diabetes patients stop taking their second line medication

Similar News

What's Putting India at Risk for Diabetes and Obesity? ICMR Study Reveals the Hidden Dietary Culprit

Real-World Case Insight: Triple FDC Therapy in a Young Diabetes Patient - Dr Naresh Kumar

Mango Consumption Linked to Improved Metabolic Health and Diabetes Prevention: Study

The Silent Killer in MASLD? It's Not Diabetes, Says New Study

Study Reveals Why Some People with Obesity Avoid Disease Through Genetic Mapping

Enhanced Efficacy of High-Dose Semaglutide in Obesity and Type 2 Diabetes: STEP UP Trials Find

Smoking Raises Risk for All Type-2 Diabetes Subtypes, Especially Severe Ones: Study

Only 1 in 5 People with Diabetes Have Optimal Blood Sugar Control: Study Finds